The Neisseria gonorrhoeae Methionine Sulfoxide Reductase (MsrA/B) Is a Surface Exposed, Immunogenic, Vaccine Candidate

Frontiers in Immunology
Freda E-C JenMichael P Jennings

Abstract

Control of the sexually transmitted infection gonorrhea is a major public health challenge, due to the recent emergence of multidrug resistant strains of Neisseria gonorrhoeae, and there is an urgent need for novel therapies or a vaccine to prevent gonococcal disease. In this study, we evaluated the methionine sulfoxide reductase (MsrA/B) of N. gonorrhoeae as a potential vaccine candidate, in terms of its expression, sequence conservation, localization, immunogenicity, and the functional activity of antibodies raised to it. Gonococcal MsrA/B has previously been shown to reduce methionine sulfoxide [Met(O)] to methionine (Met) in oxidized proteins and protect against oxidative stress. Here we have shown that the gene encoding MsrA/B is present, highly conserved, and expressed in all N. gonorrhoeae strains investigated, and we determined that MsrA/B is surface is exposed on N. gonorrhoeae. Recombinant MsrA/B is immunogenic, and mice immunized with MsrA/B and either aluminum hydroxide gel adjuvant or Freund's adjuvant generated a humoral immune response, with predominantly IgG1 antibodies. Higher titers of IgG2a, IgG2b, and IgG3 were detected in mice immunized with MsrA/B-Freund's adjuvant compared to MsrA/B-aluminum hydroxide adj...Continue Reading

References

Jan 1, 1994·Methods in Enzymology·D P McQuillenP A Rice
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·T M WizemannH R Masure
Dec 31, 1997·Molecular & General Genetics : MGG·J MelliesT F Meyer
Aug 29, 2002·Acta Crystallographica. Section D, Biological Crystallography·Brice KauffmannAndré Aubry
Feb 1, 2005·Biochimica Et Biophysica Acta·Herbert WeissbachNathan Brot
Feb 1, 2005·Biochimica Et Biophysica Acta·Benjamin EzratyFrédéric Barras
Jun 9, 2006·Microbiology and Molecular Biology Reviews : MMBR·Kate L SeibAlastair G McEwan
Feb 8, 2008·Journal of Molecular Biology·Fanomezana M RanaivosonFrédérique Favier
Nov 1, 2008·The Journal of Infectious Diseases·Christopher T SteichenMichael A Apicella
Jul 5, 2011·The Journal of Physical Chemistry. B·Jesse J RobinetJames W Gauld
Jan 15, 2013·Biochemical and Biophysical Research Communications·Lucy K ShewellMichael P Jennings
Apr 24, 2014·The Journal of Biological Chemistry·Martine P BosJan Tommassen
Feb 14, 2015·PloS One·Vineet K SinghJackob Moskovitz
Jan 26, 2016·Critical Reviews in Microbiology·Jennifer L EdwardsKate L Seib
Jul 14, 2017·The Lancet Infectious Diseases·Magnus UnemoChristopher K Fairley
Sep 10, 2017·Annual Review of Microbiology·Peter A RiceAnn E Jerse

❮ Previous
Next ❯

Datasets Mentioned

BETA
EEH61172.1

Methods Mentioned

BETA
PCR
ELISAs
chip
Biosensor
ELISA

Software Mentioned

TMHMM
BLAST
Biacore T200
Pioneer
OneStep
Qdat

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.